Preparing to Pitch In A Virtual World
Source: Life Science Leader
Josh Brumm, CEO of Dyne Therapeutics, discusses the importance of sharing your company’s vision and mission early when preparing to pitch virtually. Fellow panelists Keith Vendola, M.D., CSO and head of strategy at Rezolute; and Markus Warmuth, M.D., CEO of Monte Rosa Therapeutics; add to the conversation in this video segment of a larger executive virtual roundtable (EVR) (view full video here) on the topic of Pitching And Fundraising In The New Norm.
This website uses cookies to ensure you get the best experience on our website. Learn more